Effective management of poisoning and overdose cases is a crucial component of clinical practice, particularly for pharmacists who may work in emergency or hospital settings. As such, candidates preparing for the Pharmacy Examining Board of Canada (PEBC) should develop a thorough understanding of the types and appropriate administration of antidotes used in various toxicological emergencies. This guide, provides an essential reference on the antidotes commonly required for the treatment of specific drug and chemical overdoses. It serves as a resource for understanding the mechanisms of these antidotes, appropriate dosing guidelines, and practical considerations that are relevant for pharmacy practice in Canada.
Pharmacies, especially those serving hospitals or large clinics, often face challenges in stocking sufficient quantities of critical antidotes due to constraints related to cost, storage, and the potential need to treat multiple patients simultaneously. The selection and quantity of antidotes stocked should be tailored based on factors such as geographic location, the nature of the surrounding community, and the types of emergencies typically encountered. For instance, rural areas may face higher risks of venomous snake bites, while industrial areas may see more incidents related to chemical exposures. Pharmacists must balance the need for sufficient antidote stock with the costs associated with maintaining an inventory of potentially expensive medications.
In Canada, pharmacists should consult with the Canadian Association of Poison Control Centres or local poison control authorities for up-to-date guidelines on antidote stocking requirements. This collaboration ensures that, in emergencies, the necessary support is available to optimize patient outcomes. Poison control centers also play an integral role in guiding healthcare providers through case-specific antidote administration, considering factors like patient weight, ingestion amount, and comorbidities. Additionally, poison control staff often provide follow-up to monitor patient recovery and adjust treatment protocols as needed.
|
Drug or Antidote |
Used For Poisonings or Overdoses with |
|
Acetylcysteine |
Acetaminophen |
|
Atropine sulfate |
Beta-blockers, Calcium channel blockers, Clonidine, Digoxin, Local anesthetics |
|
Atropine sulfate (continued) |
Organophosphate pesticides, nerve agents, Carbamate insecticides |
|
Calcium chloride 10% |
Beta-blockers, CCBs, Fluoride |
|
Calcium disodium versenate (edetate calcium disodium) |
Lead |
|
Calcium gluconate 10% |
Beta-blockers, CCBs, Fluoride |
|
Calcium trisodium pentetate |
Americium, Curium, Plutonium |
|
Activated Charcoal |
Several medications and poisons |
|
Cyproheptadine |
Serotonergic drugs |
|
Deferoxamine mesylate |
Iron |
|
Dextrose (D50) |
Hypoglycemic agents |
|
Digoxin Immune Fab |
Digoxin |
|
Dimercaprol |
Arsenic, Gold, Lead, Mercury |
|
Ethanol |
Ethylene glycol (antifreeze), Methanol |
|
Flumazenil |
Benzodiazepines |
|
Fomepizole |
Ethylene glycol, Methanol |
|
Glucagon |
Beta-blockers, CCBs |
|
Glucarpidase |
Methotrexate |
|
Hydroxocobalamin |
Cyanide |
|
Regular Insulin |
Beta-blockers, CCBs |
|
Leucovorin |
Methotrexate, Methanol |
|
Levocarnitine |
Valproic acid |
|
Methylene blue |
Methemoglobinemia, CCB |
|
Naloxone |
Opioids |
|
Octreotide |
Sulfonylureas |
|
Physostigmine salicylate |
Anticholinergics |
|
Sodium bicarbonate |
Tricyclic antidepressants, Cocaine, Local anesthetics |
|
Thiamine |
Ethylene glycol toxicity, Ethanol (chronic alcohol misuse) |